Optometrists in Massachusetts - Medicare Status, Address, Contact

2124 Optometrists found. Showing 281 - 300

Kelsey Jordan, OD Optometrist Medicare: Medicare Enrolled Practice Location: 150 S Huntington Ave, Boston, MA 02130 Phone: 857-364-6669

Pearle Vision Optometrist Medicare: Medicare Enrolled Practice Location: 100 City Hall Plz, Boston, MA 02108 Phone: 617-367-2020    Fax: 617-523-7040

Dr. Gerald J Selvin, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 150 S Huntington Ave, 112-0, Boston, MA 02130 Phone: 857-364-6041

Jeffrey Kublin Od, Pc Optometrist Medicare: Medicare Enrolled Practice Location: 175 Cambridge St, Boston, MA 02114 Phone: 617-523-7006    Fax: 617-523-5006

Marjorie Rah, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 930 Commonwealth Ave, Suite 2a New England Eye Institute, Boston, MA 02215 Phone: 617-262-2020    Fax: 617-236-6323

Dr. Andrew Jon Rabkin, DOCTOR OF OPTOMETRY Optometrist Medicare: May Accept Medicare Assignments Practice Location: 175 Cambridge St, Boston, MA 02114 Phone: 617-523-7006    Fax: 617-523-5006

Lixin Zhang, OD Optometrist Medicare: Medicare Enrolled Practice Location: 424 Beacon St, Boston, MA 02115 Phone: 617-266-2030

Amy Croteau Watts, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3185    Fax: 617-573-6871

Eric Moulton, O.D., PH.D Optometrist Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Department Of Ophthalmology, Fegan 4, Boston, MA 02115 Phone: 617-355-6401

Dr. Emily Katrina Wiecek, OD, PHD Optometrist - Pediatrics Medicare: Medicare Enrolled Practice Location: 930 Commonwealth Ave, Boston, MA 02215 Phone: 617-262-2020

Dr. Rosanna C Lamalva, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 10 City Hall Ave, Boston, MA 02108 Phone: 617-523-3639    Fax: 617-523-0393

Jacob Hillard, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 150 S Huntington Ave, Optometry, Boston, MA 02130 Phone: 617-232-9500

George Lakkis Optometrist Medicare: Not Enrolled in Medicare Practice Location: 607 Boylston St, Cohen's Fashion Optical, Boston, MA 02116 Phone: 617-236-5500    Fax: 617-236-5505

Patricia Fox, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10 Huntington Ave, Boston, MA 02116 Phone: 617-859-0630    Fax: 617-859-0632

Dr. S. Michelle Quintero-chica, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 287 Newbury St, Boston, MA 02115 Phone: 617-424-9292    Fax: 617-267-5606

State Street Eye Health Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 33 Broad St, Boston, MA 02109 Phone: 617-742-7200    Fax: 617-742-7272

Dr. Azadeh Kelly, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 33 Broad St Lbby 2, Boston, MA 02109 Phone: 617-742-7200    Fax: 617-742-7272

Dr. Melissa Tom-kun, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 450 Washington St, Boston, MA 02111 Phone: 617-988-8136

Clifford Scott, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1255 Boylston St, Boston, MA 02215 Phone: 617-262-2020    Fax: 617-236-6323

Dr. Duane D Smith, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 175 Cambridge St, Boston, MA 02114 Phone: 617-523-5600    Fax: 617-523-7006

News Archive

Genentech's combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated metastatic non-squamous non-small cell lung cancer.

New method developed to synthesise a set of potential glycosidase inhibitors

In many biological and pathological processes, glycosidase enzymes attack glycosidic bonds in carbohydrates, glycoproteins, and glycolipids. The ability to modify or block these processes by specific glycosidase inhibitors forms the basis for their potential use in the treatment of viral infections, cancer, and genetic disorders.

Newly discovered antibody broadly inhibits multiple strains of pandemic norovirus

Researchers at the University of North Carolina at Chapel Hill Gillings School of Global Public Health and their colleagues at the University of Texas at Austin and the National Institutes of Health Vaccine Research Center have discovered an antibody that broadly inhibits multiple strains of pandemic norovirus, a major step forward in the development of an effective vaccine for the dreaded stomach virus.

NIH awards K23 grant to study effects of carbon dioxide levels after cardiac arrest

The NIH-National Heart Lung and Blood Institute has awarded Brian W. Roberts, MD, emergency medicine physician at Cooper University Health Care and Assistant Professor of Emergency Medicine at Cooper Medical School of Rowan University (CMSRU), a Mentored Patient-Oriented Career Development grant (K23) to study post-resuscitation partial pressure of arterial carbon dioxide and neurological outcome after cardiac arrest.

FDA issues complete response for Rituxan, a drug for treating chronic lymphocytic leukemia

Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) issued a complete response on the companies' applications for Rituxan® (rituximab) plus fludarabine and cyclophosphamide (FC) for the treatment of people with previously untreated and previously treated chronic lymphocytic leukemia (CLL).

Read more Medical News

› Verified 5 days ago

• «
• 10
• 11
• 12
• 13
• 14
• 15(current)
• 16
• 17
• 18
• 19
• 20
• »